Corient Private Wealth
LFMD icon

Corient Private Wealth’s LifeMD LFMD Stock Holding History

Corient Private Wealth’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.8K Sell
15,167
-14,833
-49% -$51.3K ﹤0.01% 2753
2025
Q4 		$102K Buy
30,000
+14,860
+98% +$72.1K ﹤0.01% 2645
2025
Q3 		$103K Sell
15,140
-1,007
-6% -$8.32K ﹤0.01% 2439
2025
Q2 		$220K Buy
16,147
+1,007
+7% +$9.51K ﹤0.01% 2180
2025
Q1 		$82.4K Hold
15,140
– – ﹤0.01% 2188
2024
Q4 		$74.9K Hold
15,140
– – ﹤0.01% 2252
2024
Q3 		$79.3K Buy
15,140
+85
+0.6% +$490 ﹤0.01% 2358
2024
Q2 		$103K Buy
15,055
+55
+0.4% +$503 ﹤0.01% 2211
2024
Q1 		$154K Hold
15,000
– – ﹤0.01% 2135
2023
Q4 		$124K Hold
15,000
– – ﹤0.01% 2137
2023
Q3 		$93.8K Hold
15,000
– – ﹤0.01% 2026
2023
Q2 		$65.3K Hold
15,000
– – ﹤0.01% 2004
2023
Q1 		$25.5K Hold
15,000
– – ﹤0.01% 1967
2022
Q4 		$29.1K Buy
+15,000
New +$33.6K ﹤0.01% 1658

Other funds holding LFMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Corient Private Wealth's LFMD Position: Q1 2026 in Review

Corient Private Wealth reduced its LifeMD (LFMD) stake by 49% in Q1 2026, selling an estimated $51.3K and leaving 15,167 shares worth $54.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2753.

Corient Private Wealth first reported a position in LFMD in Q4 2022 and has held it in 14 quarters since. The position peaked at $220K in Q2 2025. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

  • Corient Private Wealth held 15,167 shares of LifeMD worth $54.8K as of Q1 2026.
  • Corient Private Wealth sold 14,833 LifeMD shares in Q1 2026, an estimated $51.3K.
  • LifeMD made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2753 holding.
  • Corient Private Wealth first reported a position in LifeMD in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's LifeMD position peaked at $220K in Q2 2025.
  • 102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.